Millie was offered a pioneering drug treatment at the hospital, which dramatically reduced the size of a potentially lethal birthmark which was restricting her breathing.
The drug Millie was given was Propranolol, which had been shown to successfully treat the condition in a clinical trial in France.
Doctors at the hospital had previously diagnosed Millie with a haemangioma, a birthmark caused by a benign tumour of the blood vessels in the skin.
Jane Linward, clinical nurse specialist for Dermatology at GOSH said: “We are delighted to see Millie is doing so well.”
Notes to Editors
With the UCL Institute of Child Health, we are the largest centre for paediatric research outside the US and play a key role in training children’s health specialists for the future.
Our charity needs to raise £50 million every year to help rebuild and refurbish Great Ormond Street Hospital, buy vital equipment and fund pioneering research. With your help we provide world class care to our very ill children and their families.